Todd P. Branning Neu Base Therapeutics, Inc. (NBSE) insider trading activity

NBSE Quotes by TradingView

Todd P. Branning is Chief Financial Officer of NeuBase Therapeutics, Inc.. Currently has a direct ownership of 84,200 shares of NBSE, which is worth approximately $0. The most recent transaction as insider was on Mar 16, 2023, when has been sold 54,200 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 84.2K
0% 3M change
0% 12M change
Total Value Held $0

Todd P. Branning Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 16 2023
BUY
Grant, award, or other acquisition
-
54,200 Added 39.16%
84,200 Common Stock
Mar 18 2022
BUY
Open market or private purchase
$18,100 $1.81 p/Share
10,000 Added 25.0%
30,000 Common Stock
Mar 17 2022
BUY
Open market or private purchase
$17,400 $1.74 p/Share
10,000 Added 33.33%
20,000 Common Stock
Mar 16 2022
BUY
Open market or private purchase
$16,200 $1.62 p/Share
10,000 Added 50.0%
10,000 Common Stock

Also insider at

PHAT
Phathom Pharmaceuticals, Inc. Healthcare
Chief Financial Officer
TPB

Todd P. Branning

Chief Financial Officer
Florham Park, NJ

Track Institutional and Insider Activities on NBSE

Follow NeuBase Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBSE shares.

Notify only if

Insider Trading

Get notified when an Neu Base Therapeutics, Inc. insider buys or sells NBSE shares.

Notify only if

News

Receive news related to NeuBase Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NBSE